These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32671657)

  • 1. Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats.
    Ueda H; Narumi K; Sato Y; Furugen A; Kobayashi M; Iseki K
    Pharmacol Rep; 2020 Oct; 72(5):1426-1432. PubMed ID: 32671657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
    Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K
    Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
    Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
    Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.
    Suzuki K; Doki K; Homma M; Tamaki H; Hori S; Ohtani H; Sawada Y; Kohda Y
    Br J Clin Pharmacol; 2009 Jan; 67(1):44-9. PubMed ID: 19076159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
    Iwaki M; Shimada H; Irino Y; Take M; Egashira S
    Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
    Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.
    Ikemura K; Hamada Y; Kaya C; Enokiya T; Muraki Y; Nakahara H; Fujimoto H; Kobayashi T; Iwamoto T; Okuda M
    Drug Metab Dispos; 2016 Oct; 44(10):1543-9. PubMed ID: 27465369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate.
    Jia Y; Liu Z; Wang C; Meng Q; Huo X; Liu Q; Sun H; Sun P; Yang X; Ma X; Liu K
    Toxicol Appl Pharmacol; 2016 Sep; 306():27-35. PubMed ID: 27377006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.
    Wang X; Song Y; Wang J; He J; Liu R; Li X; Huang H; Zhang J
    Int J Clin Pharm; 2020 Feb; 42(1):23-30. PubMed ID: 31916121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole.
    Qi F; Zhu L; Li N; Ge T; Xu G; Liao S
    Int J Antimicrob Agents; 2017 Apr; 49(4):403-409. PubMed ID: 28159656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 14. The key role of organic anion transporter 3 in the drug-drug interaction between tranilast and methotrexate.
    Wang J; Yuan W; Shen Q; Wu Q; Jiang Z; Wu W; Zhang L; Huang X
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22983. PubMed ID: 35019195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
    Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
    Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.
    Reeves DJ; Moore ES; Bascom D; Rensing B
    Br J Clin Pharmacol; 2014 Sep; 78(3):565-71. PubMed ID: 24646036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate.
    Liu Q; Wang C; Meng Q; Huo X; Sun H; Peng J; Ma X; Sun P; Liu K
    Pharm Res; 2014 May; 31(5):1120-32. PubMed ID: 24242937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
    Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-interventional retrospective cohort study of the interaction between methotrexate and proton pump inhibitors or aspirin.
    Boerrigter E; Crul M
    Ann Pharm Fr; 2017 Sep; 75(5):344-348. PubMed ID: 28705331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.